LeLaf

SONN: Higher price rejection fter Gap up

Short
NASDAQ:SONN   Sonnet BioTherapeutics Holdings, Inc.
Higher Price rejection after GAP up + Spike
May try to fill the gap down yet again.

If confirmed
PT1 = 3,34
PT2 = 2,76 (For Gap Fill)
Could see even lower
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.